تحميل...
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
The Phase II clinical trials aim to assess the therapeutic efficacy of a new drug. The therapeutic efficacy has been often quantified by response rate such as overall response rate or survival probability in the Phase II setting. However, there is a strong desire to use survival time, which is the g...
محفوظ في:
| الحاوية / القاعدة: | PLoS One |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Public Library of Science
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870013/ https://ncbi.nlm.nih.gov/pubmed/33556130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0246448 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|